• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 UNK SHOULDER HUMERAL STEM DELTA XTEND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 UNK SHOULDER HUMERAL STEM DELTA XTEND Back to Search Results
Catalog Number UNK SHOULDER HUMERAL
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Bone Fracture(s) (1870); Muscular Rigidity (1968); Nerve Damage (1979); Joint Laxity (4526); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/01/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Literature article entitled "long-term impact of scapular notching after reverse shoulder arthroplasty¿ written by c.Spiry, j.Berhouet & c.Agout, g.Bacle, luc favard; published by international orthopaedics published online 16 march 2021was reviewed.The article's purpose ¿sought to determine how scapular notching changes over time and how it impacts shoulder function and the glenoid implant¿.Patient data: between 1993 and 2006, 81 patients (91 shoulders) underwent rsa for primary glenohumeral osteoarthritis or massive cuff tear with or without osteoarthritis.There were 67 women and 14 men.All patients were operated upon in the beach chair position.The deltopectoral approach was used in 72 shoulders and the anterosuperior approach in 19 shoulders.The delta reverse shoulder system (depuy, warsaw, in) was used in 40 shoulders and the competitor aequalis reverse shoulder system was used in 51 shoulders; both implants had exactly the same design with 155° humeral cup/head inclination.The humeral stem was cemented in 29 shoulders.Cement manufacturer not provided.The glenoid baseplate was never cemented.All glenospheres were 36 mm in diameter.The pe insert was lateralized in 80 shoulders and standard in 11 shoulders.Depuy products: delta reverse shoulder system adverse events: instability, infection, periprosthetic humeral fractures, aseptic glenoid loosening, partial glenoid disassembly, humeral loosening, stiffness, scapular notching, ulnar nerve compression, irrigation and debridement, orif, device revision and replacement.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: the device associated with this reported event was not returned.Available xray evidence included in the study was reviewed.No failure of any depuy product can be observed.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed, and the investigation will be re-opened as necessary.Device history lot: a manufacturing records evaluation (mre) was not performed as no lot number was provided for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK SHOULDER HUMERAL STEM DELTA XTEND
Type of Device
SHOULDER HUMERAL STEM
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key12420867
MDR Text Key269762819
Report Number1818910-2021-19264
Device Sequence Number1
Product Code HSD
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 08/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/03/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SHOULDER HUMERAL
Was Device Available for Evaluation? No
Date Manufacturer Received10/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-